Kotak Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Kotak Healthcare Fund - Regular (G)
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹227 Cr | ₹464 Cr |
| Min Investment | ₹5000 | ₹100 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹100 |
| Launch Date | 08 Nov 2021 | 11 Dec 2023 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | NIFTY Healthcare TRI |
| Turn Over | % | % |
| Expense Ratio | 2.35 | 2.39 |
| Manager | Rohan Korde | Abhishek Bisen |
| ISIN Code | INF00XX01BL5 | INF174KA1PW4 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Kotak Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| 1 Month | 3.06% | 4% |
| 6 Month | 4.04% | 6.56% |
| 1 Year | -2.79% | 0.66% |
| 3 Year | 18.71% | - |
| 5 Year | - | - |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| 6 Month | 1.79% | 3.3% |
| 1 Year | 4.26% | 8.37% |
| 3 Year | 17.98% | - |
| 5 Year | - | - |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| 1 Year | 18.94% | 13.51% |
| 3 Year | 20.21% | - |
| 5 Year | - | - |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| Standard Deviation | 15.64% | - |
| Sharp | 0.77% | - |
| Beta | 0.95% | - |
| Alpha | -2.74% | - |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| Name | Rohan Korde | Abhishek Bisen |
| Total AUM | ₹4626 Cr | ₹0 Cr |
| Funds Managed | 10 | 33 |
| ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| Others | 3.56 | 9.77 |
| Large Cap | 29.45 | 27.79 |
| Mid Cap | 37.33 | 31.93 |
| Small Cap | 29.66 | 30.51 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Kotak Healthcare Fund - Regular (G) |
|---|---|---|
| Others | 1.52 | 2.32 |
| Healthcare | 91.78 | 95.12 |
| Basic Materials | 3.67 | 2.56 |
| Industrials | 1.86 | - |
| Financial Services | 1.17 | - |
Top Comparisons
HDFC Multi-Asset Fund - Growth Option
3Y Returns14.77%
Aditya Birla Sun Life Multi Asset Allocation Fund-Regular Growth
3Y Returns0%
WhiteOak Capital ELSS Tax Saver Fund Regular Plan Growth
3Y Returns19.96%
Motilal Oswal ELSS Tax Saver Fund (MOFLTE) - Regular Plan - Growth Option
3Y Returns23.89%
Sundaram Liquid Fund (G)
3Y Returns6.94%
Mirae Asset Liquid Fund - Growth
3Y Returns6.98%
ICICI Prudential Equity & Debt Fund - Growth
3Y Returns18.95%
Mahindra Manulife Aggressive Hybrid Fund - Regular Plan - Growth
3Y Returns16.51%